| Sign In to gain access to subscriptions and/or personal tools. |
A Field Trial of Combined Measles- Mumps-Rubella VaccineSatisfactory Immunization with 188 Children in ChileServido Nacional de Salud, Santiago, Chile
Servido Nacional de Salud, Santiago, Chile
Servido Nacional de Salud, Santiago, Chile
Servido Nacional de Salud, Santiago, Chile
Servido Nacional de Salud, Santiago, Chile
Division of Virus and Cell Biology Research, Merck Institute for Therapeutic Research, West Point, Pa. 19486 This report presents confirming evidence for the immunizing value of a trivalent combined measles-mumps-rubella vaccine (M-M-R), based on studies with 188 children in Chile. All of the children de veloped antibody against measles virus and 96 per cent developed antibodies against mumps and rubella. No clinical reaction occurred other than that expected to follow measles vaccine given alone.
Clinical Pediatrics, Vol. 12, No. 3,
170-172 (1973) |
|
||

